ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Multifunctional PDGF Nanofiber and MnCe Nanozyme-Incorporated Composite Hydrogel for Enhanced Skeletal Muscle Regeneration.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Volumetric muscle loss (VML) results in sustained functional impairment owing to inadequate endogenous muscle regeneration. Herein, we report a multifunctional, injectable and adhesive hydrogel designed to synergistically enhance myogenic regeneration and reconstruct a pro-regenerative microenvironment for VML repair. The GelMA hydrogel integrates platelet-derived growth factor-mimetic supramolecular nanofibers (PDGF-NF) and a cerium-manganese nanozyme (MnCe). The PDGF-NF recapitulate endogenous myokine signaling, thereby promoting myoblast proliferation and myogenic differentiation, while overcoming the intrinsic limitations of recombinant growth factors. Concurrently, the MnCe nanozyme efficiently scavenges excessive reactive oxygen species and modulates macrophage polarization from the pro-inflammatory M1 phenotype toward the pro-regenerative M2 phenotype, collectively alleviating oxidative stress, chronic inflammation at the defect site. As a result, the composite hydrogel establishes a favorable microenvironment that supports angiogenesis and muscle tissue remodeling. In a VML animal model, the MnCe-PDGF@GM hydrogel enhanced myofiber regeneration by 181.5%, and reduced fibrotic deposition by 55.8%, resulting in markedly improved functional recovery at 4 weeks. This work highlights a biomimetic and microenvironment-adaptive strategy that integrates myokine-mimicking nanofibers and multifunctional nanozymes, offering a promising therapeutic platform for effective VML regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.